Clinical Research Directory
Browse clinical research sites, groups, and studies.
Smallpox Vaccine for Mpox Post-Exposure Prophylaxis: A Cluster RCT
Sponsor: McMaster University
Summary
A cluster randomized controlled trial to determine if smallpox vaccine reduces secondary cases and symptom severity in persons exposed to mpox.
Official title: SMART (Smallpox Vaccine for Mpox Post-Exposure Prophylaxis: A Cluster Randomized Controlled Trial)
Key Details
Gender
All
Age Range
2 Years - Any
Study Type
INTERVENTIONAL
Enrollment
3000
Start Date
2024-09-17
Completion Date
2026-12-01
Last Updated
2025-07-06
Healthy Volunteers
Yes
Conditions
Interventions
Bavarian Nordic smallpox vaccine
A single dose of the Bavarian Nordic smallpox vaccine will be given at baseline.
Typhoid VI Polysaccharide Vaccine Injectable Solution
A single dose of the typhoid vaccine will be given at baseline.
Locations (10)
Catholic University of Bukavu
Kinshasa, Bukavu, Democratic Republic of the Congo
Federal Medical Center
Abuja, Nigeria
University of Abuja Teaching Hospital
Abuja, Nigeria
University of Ibadan
Ibadan, Nigeria
Irrua Specialist Teaching Hospital
Irrua, Nigeria
Aminu Kano Teaching Hospital
Kano, Nigeria
Lagos University Teaching Hospital
Lagos, Nigeria
Niger Delta Teaching Hospital
Okolobiri, Nigeria
University of Port Harcourt Teaching Hospital
Port Harcourt, Nigeria
Makerere University Lung Institute
Kampala, Uganda